Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2039)	11/16/2007 4:57:32 PM
From: Jibacoa	Read Replies (2) \| Respond to of 3722

IVD was up for 2nd day on a roll. The stock was up 29% albeit the volume was less than yesterday.<g> bigcharts.marketwatch.com IVD is a division of IVAX, which at one time was among Florida's largest pharmaceutical firms, until it was acquired by Teva Pharmaceutical for $7.4 B in 2005.(Dr. Phillip Frost had built the company form the original Key Pharmaceutical, which he started in 1972 with $100Ks.<g>) IVD is still trading around 0.5xBV & although there are 27.6M shrs out, the float is < 7M, since Teva through Ivax controls > 70% of the shrs.<g> IVD reported a net loss of $7,841,000 for the 3rdQ, but there were non-cash charges totaling $7,526,000 As of Sep 30, IVD had 25,255,467 of total assets & 5,539,549 of total liabilities.It seems the stock has a chance of getting back to the $1 or even the $2 level.<g> bigcharts.marketwatch.com Bernard

To: Jibacoa who wrote (2039)	1/26/2008 12:09:54 AM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

LMRA Was up 35.48% on volume of 694,894 >3x its ADV & continued to hold its gain AHs. bigcharts.marketwatch.com As previously mentioned,I traded LMRA in 2006 during its Oct-Nov run, which started at a level lower than its present one. At that time what caused the spike was its presentation at the Westergaard SmallCap conference & the announcement of the successful testing of its millimeter wave wireless bridge, which reportedly,is able to transmit vast amounts of data by a variety of high speed telecommunications networks. bigcharts.marketwatch.com. My interest on LMRA is because of its NanoCapture arrays and ProteomicProcessor, a field in which there is a good amount of competition with several companies involved,many of them in this list: functionalgenomics.org.uk In July LMRA formed a wholly owned subsidiary, Plexera Bioscience,where it transfered the operations of its bioscience business and is led by Joseph Vallner, Ph.D, who was before at CEGE & years ago at Syntex & GD Searle. Leroy Hood, M.D., Ph.D., president and co-founder of the Institute for Systems Biology, & Josh LaBaer, M.D., Ph.D., founder and director of the Institute of Proteomics at Harvard Medical School, joined LMRA's Scientific Advisory Board in April 2006. ir.lumera.com Disclosure: I sold most of my shares in 2006 at $10, but still have a small position. The stock is starting to get off from the DT coming from its Oct15 H at $4.74 (LMRA has substantial amount of resistance at that level from its Jul, Sep & Oct Hs.) The analysts don't seem to have an advertised target for LMRA of which I am aware, but I will continue to hold mine around $5 for 2008, which would still be a nice gain from present levels. Of course if it can close above $5 & it has some good news I may have to raise that "target".<g> bigcharts.marketwatch.com Bernard